Generic Medicines
Taj Pharma is the largest generic pharmaceutical company in India. We hold top positions in different established markets worldwide generics markets..
Note: (UNDER FDA APPROVAL)
Identification
Name Troparil
Synonymous (-)-2ß-Carbomethoxy-3ß-phenyltropane; 2-beta-Methoxycarbonyl-3-beta-phenyltropane; (exo,exo)-8-Methyl-3-phenyl-8-azabicyclo(3.2.1)octane-2-carboxylic acid methyl ester; WIN 35065; ß-CPT
ß-CPT has similar effects to cocaine in animal studies, but no instances of this compound being abused recreationally by humans are known. Despite being easily made by the reaction of methylecgonidine with phenylmagnesium bromide,the relative scarcity of methylecgonidine and the demanding reaction conditions required for the synthesis put production of this compound beyond the capacity of most illicit drug manufacturers, and legitimate supplies of ß-CPT are available only in very small quantities for a very high price.
Legal Status : The legal status of CPT is unclear. Sigma-Aldrich claims that it is a Schedule II / Class B drug in the USA and UK, but it is not listed in any controlled drugs legislation or published lists of illegal drugs from the relevant government departments in these jurisdictions. Nevertheless, CPT may be considered a controlled substance analogue of cocaine on the grounds of its related chemical structure in some jurisdictions such as Canada, Australia and New Zealand.
This is somewhat unclear as there has not been any legal precedent set to determine whether a compound derived by the simplification of an illegal drug molecule (removal of an ester link in this instance) can be considered "substantially similar" to the illegal drug; all previous examples of designer drugs such as a-methylfentanyl have been derived instead by adding extra substituent groups onto the molecule, and the laws covering this area only refer to the addition or substitution of groups onto the illegal drug molecule, not their removal. An excessively broad precedent set in this area would be extremely problematic from a legal standpoint.